BlackRock Investment Management, LLC - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 24 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$6,0000.0%4,635
+17.8%
0.00%
Q4 2015$6,000
-25.0%
3,934
+7.4%
0.00%
Q3 2015$8,000
-57.9%
3,6630.0%0.00%
Q2 2015$19,0003,6630.00%
Other shareholders
CONTRAVIR PHARMACEUTICALS IN shareholders Q2 2015
NameSharesValueWeighting ↓
Prospera Financial Services Inc 176,100$287,0000.05%
RFG Advisory, LLC 40,000$65,0000.05%
Acrospire Investment Management LLC 16,551$29,0000.02%
HighTower Advisors, LLC 1,047,731$1,854,0000.02%
B. Riley Wealth Advisors, Inc. 25,958$46,0000.01%
EXENCIAL WEALTH ADVISORS, LLC 11,900$19,0000.01%
THOMPSON DAVIS & CO., INC. 3,000$5,0000.01%
LBA Wealth Management, LLC 8,000$14,0000.01%
INGALLS & SNYDER LLC 20,739$37,0000.00%
Vantage Investment Advisors, LLC 1,150$2,0000.00%
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders